Not applicableStudy completedNCT03369314What this trial is testingObservational Study of the Use of octaplasLG®.Who this might be right forThrombotic Thrombocytopenic Purpura Octapharma 263
Not applicableUnknownNCT05389007What this trial is testing.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)Who this might be right forThrombotic Thrombocytopenic Purpura Johannes Gutenberg University Mainz 156
Testing effectiveness (Phase 2)Study completedNCT01554514What this trial is testingLow Dose Rituximab in Thrombotic Thrombocytopenic PurpuraWho this might be right forThrombotic Thrombocytopenic Purpura Washington University School of Medicine 19
Not applicableLooking for participantsNCT06945861What this trial is testingImmunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)Who this might be right forThrombotic Thrombocytopenic Purpura (TTP) University Hospital, Rouen 44
Large-scale testing (Phase 3)Ended earlyNCT00799773What this trial is testingEvaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)Who this might be right forThrombotic Thrombocytopenic Purpura Carelon Research 3
Large-scale testing (Phase 3)Ended earlyNCT00411801What this trial is testingSafety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)Who this might be right forThrombotic Thrombocytopenic Purpura (TTP) Octapharma 8
Post-approval studies (Phase 4)UnknownNCT05135442What this trial is testingEfficacy and Safety of Bortezomib as First-line Treatment of Acquired TTPWho this might be right forThrombotic Thrombocytopenic Purpura, Acquired Peking Union Medical College Hospital 30
Large-scale testing (Phase 3)Study completedNCT03393975What this trial is testingBAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)Who this might be right forThrombotic Thrombocytopenic Purpura (TTP) Baxalta now part of Shire 52
Large-scale testing (Phase 3)Study completedNCT05468320What this trial is testingCaplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic PurpuraWho this might be right forThrombotic Thrombocytopenic Purpura Sanofi 51
Testing effectiveness (Phase 2)Study completedNCT01151423What this trial is testingStudy to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)Who this might be right forAcquired Thrombotic Thrombocytopenic Purpura Ablynx, a Sanofi company 75
Testing effectiveness (Phase 2)Ended earlyNCT00726544What this trial is testingClinical Outcome Study of ARC1779 Injection in Patients With Thrombotic MicroangiopathyWho this might be right forThrombotic MicroangiopathyThrombotic Thrombocytopenic Purpura Archemix Corp. 100
Not applicableWithdrawnNCT02626663What this trial is testingThe Role of Microparticles as a BiomarkerWho this might be right forAtypical Hemolytic Uremic SyndromeThrombotic Thrombocytopenic PurpuraMicroparticles+1 more University of Rochester
Not applicableUnknownNCT05785468What this trial is testingA Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)Who this might be right forThrombotic Thrombocytopenic Purpura Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1